Visanne Study to Assess Safety in Adolescents (Q65374881)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Visanne Study to Assess Safety in Adolescents
clinical trial

    Statements

    VISADO (English)
    0 references
    A Multi-center, Open Label, Single-arm Study to Investigate the Safety and Efficacy of Daily Oral Administration of 2 mg Dienogest Tablets for the Treatment of Endometriosis in Adolescents Over a Treatment Period of 52 Weeks (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    March 2011
    0 references
    March 2013
    0 references
    111
    0 references
    0 references
    0 references
    12 year
    0 references
    17 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit